Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001493152-19-016091
Filing Date
2019-10-29
Accepted
2019-10-29 15:04:50
Documents
1
Effectiveness Date
2019-10-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8621
  Complete submission text file 0001493152-19-016091.txt   10036
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-352091 | Film No.: 191176052
SIC: 7389 Services-Business Services, NEC